Companies & Products at MEDICA / COMPAMED

PASTEUR PIPETTE Code                           Material                    &

(AFP) Alpha-Fetoprotein Test is designed for the rapid qualitative determination of AFP in whole blood, serum or plasma specimens to aid in the diagnosis of Hepatocelluar Carcinoma or fetal open

Summary Urinalysis Reagent Strips are made for urinalysis of both qualita­ tive and semi-quantitative, which are in vitro reagent for diagnos­ tics. It tests Leukocytes, Nitrite, Urobili nogen,

• Test COVID-19 both IgG and IgM Ab • Rapid result in in 10min. • Whole blood (Finger prick available), serum and plasma sample • Easy to use no analyzer required • Store at room temperature or

Biomarkers are measurable parameters that can indicate pathological processes in the body. They can be measured from a tissue biopsy or a liquid biopsy like blood, urine or saliva. All specimens come

CHEXEL™  Cardiac TnI Test System - Launching is expected in Q2 2021 - CE marking is expected in Q4 2021 KEY FEATURES & BENEFITS - Rapid immunoassay - Small sample volume analysis - High

CHEXEL™  COVID-19 Antigen Test Kit - Launching is expected in December 2020 - CE marking is expected in Q1 2021 KEY FEATURES & BENEFITS - Accurate & compact/Easy-to-use - Rapid

CHEXEL™  COVID-19 IgM/IgG Test Kit (CAT# GQLAGH) KEY FEATURES & BENEFITS - CE-IVD marked - Accurate & compact/Easy-to-use - Rapid immunoassay - Small sample volume analysis - High

Absoludy COVID-19 Ag Rapid is based on immunochromatography for the qualitative determination of SARS-CoV-2 virus specific antigens in human nasopharynx swab specimen. Absoludy COVID-19 Ag Rapid Card

Absoludy COVID-19 IgM/IgG Rapid is based on the principle of an immune-chromatography in vitro test for the qualitative determination of SARS-CoV-2 virus (COVID-19) specific IgM or IgG in serum,

KEY POINTS Detection for: qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human whole blood, serum, or plasma as an aid in the diagnosis of primary and secondary COVID-19 infections.

KEY POINTS Detection for: IgG and IgM antibodies and non-structural protein antigen to Dengue virus in human whole blood, serum, or plasma Specimen volume: Serum or Plasma Specimens: for IgG/IgM Test

KEY POINTS Detection for: H.pylori antibodies in whole blood, serum, or plasma. Specimen volume: Serum or plasma Specimen: 100 μL                

KEY POINTS Detection for: Helicobacter pylori (H. pylori) antigens in human feces. Specimen volume: Refer to the test procedure; Reading time: 10 minutes; Relative sensitivity: >99.9% (95%CI*:

KEY POINTS Detection for: Hepatitis B Surface Antigen in whole blood, serum or plasma Specimen volume: Serum or Plasma specimen: 75 mL;           &

KEY POINTS Detection for: antibody to Hepatitis C Virus in whole blood, serum or plasma; Specimen volume: Serum or Plasma specimen: 25 mL;                 &

KEY POINTS Detection for: antibodies to HIV type 1, type 2 and Subtype O qualitatively in whole blood, Serum or plasma; Specimen volume: Serum or Plasma specimen 25 μL;        &

KEY POINTS Detection for: Antibodies to HIV type 1 & 2 in whole blood, serum or plasma; Specimen volume: 25 mL Serum or Plasma, or 50 mL Venipuncture Whole Blood, or 50 mL Fingerstick Whole Blood